Clinical Trials Directory

Trials / Unknown

UnknownNCT05648747

Pelvic Inflammatory Disease in COVID-19 Era

Factors Associated With an Unfavorable Clinical Course in Hospitalized Patients With Pelvic Inflammatory Disease in Post Covid 19 Era: a Multicentric Retrospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Università degli Studi di Ferrara · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country. The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.

Conditions

Interventions

TypeNameDescription
OTHERimpact of COVID-19 on Health-Seeking BehaviorsThe impact of the coronavirus disease 2019 (COVID-19) pandemic on medical services is overwhelming due to limited medical resources. During its initial surge in 2020, Italy's government rapidly established diverse public actions, which helped maintain the medical supply. However, whether the fear of being infected with COVID-19 interfered with health-seeking behavior (HSB) remains unclear. Therefore, this study aimed to elucidate whether pelvic inflammatory disease rates were affected by the COVID-19 pandemic.

Timeline

Start date
2023-01-01
Primary completion
2024-01-01
Completion
2024-01-30
First posted
2022-12-13
Last updated
2022-12-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05648747. Inclusion in this directory is not an endorsement.